Ingelson-Filpula W, Breedon S, Storey K
Cells. 2025; 13(24.
PMID: 39768165
PMC: 11674624.
DOI: 10.3390/cells13242074.
Engin A
Adv Exp Med Biol. 2024; 1460:489-538.
PMID: 39287863
DOI: 10.1007/978-3-031-63657-8_17.
Huynh M, Lyoo S, Yang D, Choi Y, Kim K
Endocrinol Metab (Seoul). 2024; 39(5):793-802.
PMID: 39212037
PMC: 11525698.
DOI: 10.3803/EnM.2024.1999.
He Y, Han S, Li H, Wu Y, Jia W, Chen Z
MedComm (2020). 2024; 5(7):e633.
PMID: 38952575
PMC: 11215284.
DOI: 10.1002/mco2.633.
Choudhury D, Ghosh D, Mondal M, Singha D, Pothuraju R, Malakar P
Cell Commun Signal. 2024; 22(1):196.
PMID: 38539200
PMC: 10976710.
DOI: 10.1186/s12964-024-01526-9.
Insulin Receptor Isoforms and Insulin Growth Factor-like Receptors: Implications in Cell Signaling, Carcinogenesis, and Chemoresistance.
Galal M, Alouch S, Alsultan B, Dahman H, Alyabis N, Alammar S
Int J Mol Sci. 2023; 24(19).
PMID: 37834454
PMC: 10573852.
DOI: 10.3390/ijms241915006.
Upregulation Attenuated the KRAS-PI3K-Rac1-Akt Axis-Mediated Bioenergetic Functions.
Hung K, Tien N, Bau D, Yao C, Chen C, Yang J
Cells. 2023; 12(18).
PMID: 37759534
PMC: 10527334.
DOI: 10.3390/cells12182313.
Effect of β-sitosterol on insulin resistance & protein expression of insulin signalling molecules in quadriceps muscle of high fat diet-induced type-2 diabetic rats.
Sekar G, G M, Krishnan M, Babu S, K P, Konduru P
Bioinformation. 2023; 18(11):1098-1104.
PMID: 37693081
PMC: 10484696.
DOI: 10.6026/973206300181098.
Phosphoinositides and intracellular calcium signaling: novel insights into phosphoinositides and calcium coupling as negative regulators of cellular signaling.
Oh B
Exp Mol Med. 2023; 55(8):1702-1712.
PMID: 37524877
PMC: 10474053.
DOI: 10.1038/s12276-023-01067-0.
Natural activators of AMPK signaling: potential role in the management of type-2 diabetes.
Chauhan S, Singh A, Rana A, Kumar S, Kumar R, Singh J
J Diabetes Metab Disord. 2023; 22(1):47-59.
PMID: 37255783
PMC: 10225395.
DOI: 10.1007/s40200-022-01155-4.
The spatial distribution of GPCR and Gβγ activity across a cell dictates PIP3 dynamics.
Wijayaratna D, Ratnayake K, Ubeysinghe S, Kankanamge D, Tennakoon M, Karunarathne A
Sci Rep. 2023; 13(1):2771.
PMID: 36797332
PMC: 9935898.
DOI: 10.1038/s41598-023-29639-0.
Modulation of the Inflammatory Response in Polycystic Ovary Syndrome (PCOS)-Searching for Epigenetic Factors.
Szukiewicz D, Trojanowski S, Kociszewska A, Szewczyk G
Int J Mol Sci. 2022; 23(23).
PMID: 36498989
PMC: 9736994.
DOI: 10.3390/ijms232314663.
Genetic parameters and genome-wide association study of digital cushion thickness in Holstein cows.
Barden M, Li B, Griffiths B, Anagnostopoulos A, Bedford C, Psifidi A
J Dairy Sci. 2022; 105(10):8237-8256.
PMID: 36028347
PMC: 9511494.
DOI: 10.3168/jds.2022-22035.
Late-afternoon endurance exercise is more effective than morning endurance exercise at improving 24-h glucose and blood lipid levels.
Kim H, Furuhashi S, Takahashi M, Chijiki H, Nanba T, Inami T
Front Endocrinol (Lausanne). 2022; 13:957239.
PMID: 35928886
PMC: 9343590.
DOI: 10.3389/fendo.2022.957239.
Membrane extraction with styrene-maleic acid copolymer results in insulin receptor autophosphorylation in the absence of ligand.
Morrison K, Wood L, Edler K, Doutch J, Price G, Koumanov F
Sci Rep. 2022; 12(1):3532.
PMID: 35241773
PMC: 8894449.
DOI: 10.1038/s41598-022-07606-5.
Phenotyping of -A Nutritional Perspective.
Eickelberg V, Luersen K, Staats S, Rimbach G
Biomolecules. 2022; 12(2).
PMID: 35204721
PMC: 8961528.
DOI: 10.3390/biom12020221.
Neuroprotective role of insulin-like growth factor 1 in auditory and other nervous systems.
Yamahara K, Yamamoto N, Kuwata F, Nakagawa T
Histol Histopathol. 2022; 37(7):609-619.
PMID: 35170014
DOI: 10.14670/HH-18-437.
Metformin and Insulin Resistance: A Review of the Underlying Mechanisms behind Changes in GLUT4-Mediated Glucose Transport.
Herman R, Kravos N, Jensterle M, Janez A, Dolzan V
Int J Mol Sci. 2022; 23(3).
PMID: 35163187
PMC: 8836112.
DOI: 10.3390/ijms23031264.
Genetic and Physiological Effects of Insulin on Human Urate Homeostasis.
Mandal A, Leask M, Estiverne C, Choi H, Merriman T, Mount D
Front Physiol. 2021; 12:713710.
PMID: 34408667
PMC: 8366499.
DOI: 10.3389/fphys.2021.713710.
Phase I trial of copanlisib, a selective PI3K inhibitor, in combination with cetuximab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
Marret G, Isambert N, Rezai K, Gal J, Saada-Bouzid E, Rolland F
Invest New Drugs. 2021; 39(6):1641-1648.
PMID: 34322775
DOI: 10.1007/s10637-021-01152-z.